• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Silo Pharma Initiates Safety Study for PTSD Drug SPC-15

LOS ANGELES- Silo Pharma Inc. a developmental-stage biopharmaceutical company, has commenced a 7-day safety and toxicology study for its lead candidate, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The study is being conducted ...

Tryp Therapeutics Announces Listing On OTCQB

LA JOLLA, California – Tryp Therapeutics (CSE: TRYP) a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today that it has submitted its application for a ...

Subscribe To Our Newsletter

Go to Top